信条 发表于 2025-3-30 09:24:45
Kenji Hashimoto4-8 November 1978. The meeting was sponsored by the Urological Group of the EORTC (European Organisation for Research in the Treatment of Cancer), the WHO Collaborating Centre for Bladder Cancer, the European Urological Association, the Italian Research Council (CNR) , Italian League against TumoursIsthmus 发表于 2025-3-30 15:47:31
Sara Poletti,Sara Dallaspezia,Sara Spadini4-8 November 1978. The meeting was sponsored by the Urological Group of the EORTC (European Organisation for Research in the Treatment of Cancer), the WHO Collaborating Centre for Bladder Cancer, the European Urological Association, the Italian Research Council (CNR) , Italian League against Tumourshemoglobin 发表于 2025-3-30 19:07:26
Ishna Sharma,Afton Koball,Ohm Sharma,Omar M. Ghanem Clinical management of bladder cancer is challenging because of the heterogeneity among bladder tumors with respect to invasion and metastasis, frequent occurrence of new tumors in the bladder among patients treated with bladder preservation treatments and poor prognosis of patients with tumors tha短程旅游 发表于 2025-3-31 00:19:07
Gabriela Amorim Pereira Sol,Alessandra da Silva,Karine Franklin Assis,Aline Silva de Aguiard clinical aspects of bladder cancer..Bladder cancer is a common cancer of the urinary tract. It is the fourth leading cause of cancer-related death among men and the seventh among women. Clinical management of bladder cancer is challenging because of the heterogeneity among bladder tumors with resp1分开 发表于 2025-3-31 04:51:39
http://reply.papertrans.cn/44/4311/431038/431038_55.pngmagnate 发表于 2025-3-31 06:13:38
Suresh Dahal,Naorem Kiranmala Devid clinical aspects of bladder cancer..Bladder cancer is a common cancer of the urinary tract. It is the fourth leading cause of cancer-related death among men and the seventh among women. Clinical management of bladder cancer is challenging because of the heterogeneity among bladder tumors with resp痛打 发表于 2025-3-31 10:15:53
http://reply.papertrans.cn/44/4311/431038/431038_57.png现任者 发表于 2025-3-31 14:50:53
http://reply.papertrans.cn/44/4311/431038/431038_58.pngTRAWL 发表于 2025-3-31 19:42:24
Yui Asaoka,Moojun Won,Young-A Lee,Yukiori Goto Clinical management of bladder cancer is challenging because of the heterogeneity among bladder tumors with respect to invasion and metastasis, frequent occurrence of new tumors in the bladder among patients treated with bladder preservation treatments and poor prognosis of patients with tumors tha现存 发表于 2025-3-31 23:14:05
http://reply.papertrans.cn/44/4311/431038/431038_60.png